Newronika S.p.A.

medical devices

About

Newronika S.p.A. is an Italian medical technology company based in Milan, specializing in advanced neurostimulation therapies for patients with neurological disorders, particularly movement disorders like Parkinson’s disease. The company is a spin-off from the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, bringing together expertise from various fields including neuroscience, biomedical engineering, and neuropsychology. Newronika has developed the AlphaDBS platform, an adaptive deep brain stimulation (DBS) system that provides personalized, real-time neuromodulation therapy. This innovative technology uses closed-loop systems to monitor patient biosignals and adjust stimulation accordingly, optimizing therapeutic outcomes. The AlphaDBS system has received CE Mark approval in Europe and an Investigational Device Exemption from the U.S. FDA, allowing for pivotal clinical trials to assess its safety and efficacy. Newronika collaborates with clinical and research partners to expand the applications of its technology across different neurological conditions, aiming to enhance the quality of life for patients worldwide.

Technologies

Outlook Amazon AWS Apache Ubuntu Mobile Friendly AI

Keywords

research adbs deep brain stimulation biosignal decoding brain devices clinical practice brain computers neuromodulation system medical equipment manufacturing biosignal interpretation neural implants medtech adaptive deep brain stimulation parkinson's disease therapy digital health telemedicine neural devices government medical devices cloud data collection healthcare equipment & supplies real-time biosignal processing brain signal analysis biotechnology clinical neuromodulation neurostimulation adaptation b2b closed-loop system regulatory compliance neurotechnology

Location

3 Via Torquato Tasso, Cologno Monzese, Lombardia, Italy, 20093

Related Companies

Companies in the same industry